Search results for "lipid A"

showing 8 items of 48 documents

Analysis of adsorption of phospholipids at the 1,2-dichloroethane/water interface by electrochemical impedance spectroscopy: A study of the effect of…

2007

Abstract The adsorption behaviour of a series of phosphatidylcholines (PCs) with saturated carbon chains of different length (DLPC, DPPC, DSPC, DAPC, and DBPC) at the electrified 1,2-dichloroethane/water interface was studied by measuring electrochemical impedance spectroscopy at the polarized interface. Two different trends in the interfacial capacitance were observed for any of the PCs the capacity dependence on the applied potential: strong adsorption occurs at negative potential with a marked decrease of C ( E ); increase of capacity is observed at positive potentials. It is demonstrated that the interfacial lipid adsorption was dependent on phospholipid concentration, applied potential…

chemistry.chemical_classificationChemistryGeneral Chemical EngineeringPhospholipid adsorptionPhospholipidAnalytical chemistryLiquid-liquid interfaceCapacitanceAnalytical ChemistryDielectric spectroscopyDichloroethanechemistry.chemical_compoundAdsorptionInterfacial capacitancePhosphatidylcholineElectrochemistrylipids (amino acids peptides and proteins)ITIESElectrochemical impedance spectroscopyAlkyl
researchProduct

A singular case of multiple acquired coagulopathies with antibodies antiphospholipid

2013

coagulopathies antiphospholipid antibodies
researchProduct

Studies on the interaction of C1q,a subcomponent of the first component of complement, with porins fromSalmonella minnesotaincorporated into artifici…

1990

AbstractPurified outer membrane proteins (OMP) of Salmonella minnesota, Re-form, were incorporated into liposomes. These induced in macrophages a chemiluminescence signal identical to that of the intact Re-form. This signal was abolished by preincubation of porin-containing liposomes with purified C1q. Incorporation of isolated OMP into black lipid membranes (BLM) resulted in channel-formation which could not be inhibited by isolated C1q. Additionally, incubation of OMP-containing liposomes with BLM resulted in pore-formation within the BLM. This was amplified when lipid A was present within the liposomes. Preincubation of OMP-containing liposomes with purified C1q abolished pore-formation …

congenital hereditary and neonatal diseases and abnormalitiesLuminescenceMacrophageLipid BilayersBiophysicsSynthetic membranePorinschemical and pharmacologic phenomenaBiochemistryIon ChannelsMembrane PotentialsLipid AMiceSalmonellaStructural BiologyGeneticsAnimalsHumansBlack lipid membraneLipid bilayerMolecular BiologyC1qCells CulturedMice Inbred BALB CLiposomeurogenital systemChemistryComplement C1qMacrophagesElectric Conductivitynutritional and metabolic diseasesMembranes ArtificialCell BiologyLiposomeKineticsCholesterolMembraneMembrane proteinBiochemistryOuter membrane proteinPorinPhosphatidylcholinesbacteriaBacterial outer membraneBacterial Outer Membrane ProteinsFEBS Letters
researchProduct

Mécanisme d’absorption intestinale des acides gras à longue chaîne : rôle émergent du CD36

2012

International audience; Excessive lipid intake, associated with a qualitative imbalance, favors the development of obesity and associated diseases. Among the organs involved in lipid homeostasis, the small intestine remains the most poorly known although it is responsible for the lipid bioavailability and largely contributes to the regulation of postprandial hypertriglyceridemia. The mechanism of long chain fatty acid (LCFA) intestinal absorption is not totally elucidated. The synthesis of recent literature indicates that the intestine is able to adapt its absorption capacity to the fat content of the diet. This adaptation takes place through a fat-coordinated induction of LBP and apolipopr…

lipid absorption[SDV]Life Sciences [q-bio]CD36Postprandial hypertriglyceridemiaMedicine (miscellaneous)lcsh:TP670-699intestinal adaptationHypertriglycéridémie postprandiale030204 cardiovascular system & hematologyBiochemistryIntestinal absorption03 medical and health sciences0302 clinical medicineLipid-binding proteinsChylomicronsmedicineCd36intestinesensing030304 developmental biologyIntestinal lipid absorption0303 health sciencesNutrition and DieteticsbiologyChemistryIntestinal lipid absorptionHypertriglyceridemiamedicine.diseaseMolecular biologySmall intestine3. Good healthBioavailabilitymedicine.anatomical_structurePostprandialBiochemistrybiology.proteinlipids (amino acids peptides and proteins)lcsh:Oils fats and waxesAbsorption intestinale des lipidesLong chain fatty acid[SDV.AEN]Life Sciences [q-bio]/Food and NutritionFood ScienceChylomicronOléagineux, Corps gras, Lipides
researchProduct

The Efflux Pump MexXY/OprM Contributes to the Tolerance and Acquired Resistance of Pseudomonas aeruginosa to Colistin

2020

The intrinsic resistance of Pseudomonas aeruginosa to polymyxins in part relies on the addition of 4-amino-4-deoxy-l-arabinose (Ara4N) molecules to the lipid A of lipopolysaccharide (LPS), through induction of operon arnBCADTEF-ugd (arn) expression. As demonstrated previously, at least three two-component regulatory systems (PmrAB, ParRS, and CprRS) are able to upregulate this operon when bacteria are exposed to colistin. In the present study, gene deletion experiments with the bioluminescent strain PAO1::lux showed that ParRS is a key element in the tolerance of P. aeruginosa to this last-resort antibiotic (i.e., resistance to early drug killing). Other loci of the ParR regulon, such as th…

medicine.drug_classOperonPolymyxinMutantMicrobial Sensitivity Testsmedicine.disease_causeMicrobiologyLipid A03 medical and health sciencesBacterial ProteinsMechanisms of ResistanceDrug Resistance BacterialmedicinePharmacology (medical)ComputingMilieux_MISCELLANEOUS030304 developmental biologyPharmacology0303 health sciencesColistin030306 microbiologyPseudomonas aeruginosaChemistryMembrane Transport ProteinsGene Expression Regulation BacterialAnti-Bacterial AgentsInfectious DiseasesRegulonPseudomonas aeruginosa[SDE]Environmental SciencesColistinlipids (amino acids peptides and proteins)EffluxGene DeletionBacterial Outer Membrane Proteinsmedicine.drugAntimicrobial Agents and Chemotherapy
researchProduct

The effect of ezetimibe on NAFLD

2015

NAFLD has become the most common liver disorder in countries, where obesity, type 2 diabetes mellitus, dyslipidemia, and metabolic syndrome are common. The strong association between these conditions and the risk of cardiovascular disease make treatment crucial. Possible interventions for NAFLD target excess body weight, insulin resistance, inflammation, oxidative stress or intestinal lipid absorption. Administration of combination therapy with a statin plus ezetimibe, associated with lifestyle changes, may represent an effective strategy because of the strong reduction in low-density lipoprotein cholesterol levels. Combination therapy is often more effective, especially when complementary …

medicine.medical_specialtyStatinSettore MED/09 - Medicina InternaCombination therapymedicine.drug_classBioinformaticsLiver disorderInsulin resistanceEzetimibeInternal medicineInternal MedicineAnimalsHumansMedicinebusiness.industryAnticholesteremic AgentsIntestinal lipid absorptionnutritional and metabolic diseasesGeneral MedicineLipid Metabolismmedicine.diseaseEzetimibeTreatment OutcomeEndocrinologyCholesterolLiverAzetidinesDrug Therapy CombinationMetabolic syndromebusinessCardiology and Cardiovascular MedicineNon-alcoholic steatohepatitiDyslipidemiamedicine.drugNon-alcoholic fatty liver disease
researchProduct

Correction to: One Year of Dapaglifozin Add-On Therapy Ameliorates Surrogate Indexes of Insulin Resistance and Adiposity in Patients with Type 2 Diab…

2021

This study investigates the effects of dapagliflozin on the visceral adiposity index (VAI), lipid accumulation product (LAP), product of triglycerides and glucose (TyG) and triglycerides to HDL-cholesterol ratio (TG/HDL-C) in patients with type 2 diabetes mellitus (T2D). In this real-life study, dapaglifozin was added to metformin alone (group 1, no. 42) or insulin plus metformin (group 2, no. 58) in 100 T2D patients. In group 1, after 6 months of dapaglifozin addition, a significant decrease in BMI (p < 0.001), waist circumference (WC) (p < 0.001), systolic blood pressure (SBP) (p = 0.009), diastolic blood pressure (DBP) (p = 0.012), mean fasting blood glucose (FBG), post-breakfast glucose…

medicine.medical_specialtyWaistendocrine system diseasesbusiness.industryEndocrinology Diabetes and MetabolismInsulinmedicine.medical_treatmentnutritional and metabolic diseasesCorrectionmedicine.diseaseGastroenterologyMetforminnot applicablechemistry.chemical_compoundInsulin resistanceBlood pressurechemistryDiabetes mellitusInternal medicineInternal MedicinemedicineDapagliflozinbusinessLipid Accumulation Productmedicine.drugDiabetes Therapy
researchProduct

Monophosphoryl lipid A coating of hydroxyethyl starch nanocapsules drastically increases uptake and maturation by dendritic cells while minimizing th…

2015

Enhancing delivery of antigens to dendritic cells (DCs) is essential for the induction of vigorous antigen-specific cellular immune responses. Aim of the present study was to evaluate the properties of hydroxyethyl starch nanocapsules (HES-NCs) functionalized with anti-CD40, anti-DEC205, interferon-γ (IFNγ) and/or monophosphoryl lipid A (MPLA) with respect to the overall uptake, the released cytokine profile, and the influence on phenotypic maturation of human monocyte-derived DCs using flow cytometry, confocal microscopy and enzyme-linked immunosorbent assays. NC uptake by DCs was significantly enhanced by functionalizing NCs with anti-CD40 or MPLA. With respect to the cytokine profile and…

medicine.medical_treatmentMonophosphoryl Lipid ANanocapsulesFlow cytometryHydroxyethyl Starch DerivativesImmune systemAntigenAdjuvants ImmunologicNanocapsulesInterferonmedicineHumansCells CulturedMicroscopy ConfocalGeneral VeterinaryGeneral Immunology and Microbiologymedicine.diagnostic_testChemistryPublic Health Environmental and Occupational HealthDendritic CellsTh1 CellsInterleukin-12Cell biologyToll-Like Receptor 4Infectious DiseasesLipid ANanomedicineBiochemistryMolecular MedicineAdjuvantCD80medicine.drugVaccine
researchProduct